Indegene Limited (NSE:INDGN)

Market Cap	126.15B
Revenue (ttm)	30.41B
Net Income (ttm)	4.46B
Shares Out	240.01M
EPS (ttm)	18.50
PE Ratio	28.42
Forward PE	25.89
Dividend	2.00 (0.38%)
Ex-Dividend Date	Jun 13, 2025

Volume	172,585
Average Volume	227,745
Open	525.00
Previous Close	525.60
Day's Range	519.50 - 533.50
52-Week Range	499.00 - 681.70
Beta	n/a
RSI	47.98
Earnings Date	Jan 29, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,158
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.